This invention relates to a class of novel dicarboxy amide derivatives of lipophilic amines which exhibit squalene synthase inhibition properties. More specifically the compounds are bis-aryl and/or heteroaryl alkyl or cycloalkylamino dicarboxy amides. Compounds of this invention reduce levels of serum cholesterol in the body without significantly reducing mevalonic metabolite synthesis. This invention relates also to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention.
这项发明涉及一类新颖的脂溶性胺的二羧酰胺衍
生物,具有
角鲨烯合酶抑制特性。更具体地说,这些化合物是双芳基和/或杂芳基烷基或环烷基
氨基二羧酰胺。这项发明的化合物可降低体内血清
胆固醇水平,而不显著降低
麦角酸代谢产物的合成。该发明还涉及使用这些化合物降低血清
胆固醇水平的药物组合物和治疗方法。